HYPD
NASDAQ
$2.72
Eyenovia Inc (HYPD)
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $6.95 (+155.51%)
Market Cap
$35M
P/B Ratio
0.78
FCF 5Y CAGR
+21.21%
Free Cash Flow Yield
-42.21%
Price Chart
Valuation
Market Cap$35M
P/S43.89
P/B0.78
Profitability
Total Revenue (TTM)$1.04M
Gross Profit (TTM)$740K
EBITDA-$33M
Operating Margin-1857%
EPS-$4.67
Financial Health
Free Cash Flow Yield-42.21%
Growth & Risk
EPS 5Y CAGR-41.24%
Revenue 5Y CAGR-23.57%
FCF 5Y CAGR+21.21%
Beta (5Y)1.61
Sharpe Ratio-0.65